Cargando…

Impact of Admission Glycemic Variability, Glucose, and Glycosylated Hemoglobin on Major Adverse Cardiac Events After Acute Myocardial Infarction

OBJECTIVE: Dysglycemia is associated with poorer prognosis in patients with acute myocardial infarction (AMI). Whether admission glycemic variability (GV) has important value in prognosis of AMI patients is still unknown. The aim of the study is to investigate the prognostic value of admission GV, g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Gong, Mi, Shu-hua, Tao, Hong, Li, Zhao, Yang, Hong-Xia, Zheng, Hong, Zhou, Yun, Tian, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609497/ https://www.ncbi.nlm.nih.gov/pubmed/23349547 http://dx.doi.org/10.2337/dc12-0925

Ejemplares similares

Comparison of in-hospital glycemic variability and admission blood glucose in predicting short-term outcomes in non-diabetes patients with ST elevation myocardial infarction underwent percutaneous coronary intervention
por: Mi, Shu-hua, et al.
Publicado: (2017)

Patterns of glycemic control using glycosylated hemoglobin in diabetics
por: Kahlon, Arunpreet Singh, et al.
Publicado: (2011)

Association between admission systolic blood pressure and major adverse cardiovascular events in patients with acute myocardial infarction
por: Pei, Junyu, et al.
Publicado: (2020)

Relationship Between Glycosylated Hemoglobin Assessment and Glucose Therapy Intensification in Patients With Diabetes Hospitalized for Acute Myocardial Infarction
por: Stolker, Joshua M., et al.
Publicado: (2012)

Prognostic value of early in-hospital glycemic excursion in elderly patients with acute myocardial infarction
por: Su, Gong, et al.
Publicado: (2013)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
por: Zheng, Meifan, et al.
Publicado: (2020)

Association between serum hemoglobin and major cardiovascular adverse event in Chinese patients with ST‐segment elevation myocardial infarction after percutaneous coronary intervention
por: Yang, Yulu, et al.
Publicado: (2021)

Impact of Long-term Glycosylated Hemoglobin in Patients with Acute Myocardial Infarction: a retrospective cohort study
por: Lee, Wonjae, et al.
Publicado: (2020)

Prevalence and association of medication nonadherence with major adverse cardiovascular events in patients with myocardial infarction
por: Hou, Yunfeng, et al.
Publicado: (2019)

Glycated hemoglobin level is an independent predictor of major adverse cardiac events after nonfatal acute myocardial infarction in nondiabetic patients: A retrospective observational study
por: Chen, Chin-Lan, et al.
Publicado: (2017)

Glycemic variability is associated with myocardial damage in nondiabetic patients with ST-elevation myocardial infarction
por: Oka, Satoshi, et al.
Publicado: (2018)

Impact of Admission Glycosylated Hemoglobin A1c on Angiographic Characteristics and Short Term Clinical Outcomes of Nondiabetic Patients with Acute ST-Segment Elevation Myocardial Infarction
por: El-sherbiny, Islam, et al.
Publicado: (2015)

The Impact of Admission Serum Creatinine on Major Adverse Clinical Events in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
por: Vinod, Poornima, et al.
Publicado: (2018)

Relationship Between Estimated Glycosylated Hemoglobin Using Flash Glucose Monitoring and Actual Measured Glycosylated Hemoglobin in a Chinese Population
por: Hu, Yun, et al.
Publicado: (2020)

Hemoglobin E disease and glycosylated hemoglobin
por: Yedla, Niharika, et al.
Publicado: (2015)

Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia
por: Attar, Rubina, et al.
Publicado: (2020)

Long‐Term Visit‐to‐Visit Glycemic Variability as a Predictor of Major Adverse Limb and Cardiovascular Events in Patients With Diabetes
por: Hsu, Jung‐Chi, et al.
Publicado: (2023)

Long-term Predictive Factors of Major Adverse Cardiac Events in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock
por: Bae, Eun Hui, et al.
Publicado: (2005)

Glycosylated Hemoglobin and Albumin-Corrected Fructosamine Are Good Indicators for Glycemic Control in Peritoneal Dialysis Patients
por: Lee, Szu-Ying, et al.
Publicado: (2013)

IDF21-0311 Pre-Admission, Diabetic Glycemic Control on 60-Day Mortality and Major Adverse Cardiovascular Events from COVID-19
por: Ruge, M., et al.
Publicado: (2022)

Clinical Nomogram to Predict Major Adverse Cardiac Events in Acute Myocardial Infarction Patients within 1 Year of Percutaneous Coronary Intervention
por: Pan, Defeng, et al.
Publicado: (2021)

An Elevated Glycemic Gap is Associated with Adverse Outcomes in Diabetic Patients with Acute Myocardial Infarction
por: Liao, Wen-I, et al.
Publicado: (2016)

Glycemic variability is complex - is glucose complexity variable?
por: van Hooijdonk, Roosmarijn TM, et al.
Publicado: (2012)

Major Adverse Cardiovascular Events: An Inevitable Outcome of ST-elevation myocardial infarction? A Literature Review
por: Poudel, Ishan, et al.
Publicado: (2019)

Biomarker for the Prediction of Major Adverse Cardiac Events in Patients with Non-ST-Segment Elevation Myocardial Infarction
por: Shon, Ho Sun, et al.
Publicado: (2017)

Serum irisin correlates to the severity of acute myocardial infarction and predicts the postoperative major adverse cardiovascular events
por: Chai, Qiaoying, et al.
Publicado: (2023)

Association of Admission Blood Glucose Level with Major Adverse Cardiac Events in Acute Coronary Syndrome; a Cohort Study
por: Alavi-Moghaddam, Mostafa, et al.
Publicado: (2019)

WCN23-0657 ADMISSION HEMOGLOBIN AS A PROGNOSTIC FACTOR FOR MAJOR ADVERSE KIDNEY EVENTS IN HOSPITALIZED PATIENTS WITH COVID-19 AND ACUTE KIDNEY INJURY
por: KORTRIGHT MALDONADO, K.M., et al.
Publicado: (2023)

Admission glycemic variability correlates with in-hospital outcomes in diabetic patients with non-ST segment elevation acute coronary syndrome undergoing percutaneous coronary intervention
por: Su, Gong, et al.
Publicado: (2018)

Increased glucose variability is associated with major adverse events in patients with infective endocarditis undergo surgical treatment
por: Liang, Mengya, et al.
Publicado: (2021)

Effects of blood glucose and glycosylated hemoglobin levels on intravenous thrombolysis in patients with acute cerebral infarction and type 2 diabetes mellitus
por: Zhang, Zhaoting, et al.
Publicado: (2019)

Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
por: Sato, Jun, et al.
Publicado: (2023)

Impaired Diastolic Recovery after Acute Myocardial Infarction as a Predictor of Adverse Events
por: Yoon, Hyun Ju, et al.
Publicado: (2015)

The utility of fasting plasma glucose in predicting glycosylated hemoglobin in type 2 diabetes
por: Al-Lawati, Jawad Ahmed, et al.
Publicado: (2007)

Evaluation of Glycemic Control in Type 2 Diabetes Mellitus using Cytomorphometry of Buccal Cells and Correlation with Glycosylated Hemoglobin
por: Karthik, K Raghavendhar, et al.
Publicado: (2015)

Admission Glucose and In-hospital Mortality after Acute Myocardial Infarction in Patients with or without Diabetes: A Cross-sectional Study
por: Zhao, Shi, et al.
Publicado: (2017)

BNP and Admission Glucose as In-Hospital Mortality Predictors in Non-ST Elevation Myocardial Infarction
por: Takada, Julio Yoshio, et al.
Publicado: (2012)

Admission glucose level and short-term mortality in older patients with acute myocardial infarction: results from the KORA Myocardial Infarction Registry
por: Mamadjanov, Temur, et al.
Publicado: (2021)

The association between 24-h blood pressure variability and major adverse cardiac events (MACE) in hospitalized patients with acute myocardial infarction: a retrospective cohort study
por: Harefa, et al.
Publicado: (2021)

Association Between Medication Adherence and 1‐Year Major Cardiovascular Adverse Events After Acute Myocardial Infarction in China
por: Shang, Pu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q9msdnt8os302fg9vmje8ac75q